Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study by McCaughan, Dorothy May et al.
This is a repository copy of Haematology nurses' perspectives of their patients' places of 
care and death: A UK qualitative interview study.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/142859/
Version: Published Version
Article:
McCaughan, Dorothy May orcid.org/0000-0001-5388-2455, Roman, Eve 
orcid.org/0000-0001-7603-3704, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X 
et al. (5 more authors) (2019) Haematology nurses' perspectives of their patients' places of
care and death: A UK qualitative interview study. European journal of oncology nursing. pp.
70-80. ISSN 1462-3889 
https://doi.org/10.1016/j.ejon.2019.02.003
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Contents lists available at ScienceDirect
European Journal of Oncology Nursing
journal homepage: www.elsevier.com/locate/ejon
Haematology nurses' perspectives of their patients' places of care and death:
A UK qualitative interview study
Dorothy McCaughana,∗, Eve Romana, Alexandra G. Smitha, Anne C. Garryb, Miriam J. Johnsonc,
Russell D. Patmored, Martin R. Howarde, Debra A. Howella
a Epidemiology & Cancer Statistics Group, University of York, York, YO10 5DD, UK
bDepartment of Palliative Care, York Hospital, York, YO31 8HE, UK
cWolfson Palliative Care Research Centre, University of Hull, Hull, HU6 7RX, UK
dQueen's Centre for Oncology and Haematology, Castle Hill Hospital, Hull, HU16 5JQ, UK
e Department of Haematology, York Hospital, York, YO31 8HE, UK
A R T I C L E I N F O
Keywords:
Haematological malignancy
Haematology nurse
Place of care
Place of death
A B S T R A C T
Purpose: Patients with haematological malignancies are more likely to die in hospital, and less likely to access
palliative care than people with other cancers, though the reasons for this are not well understood. The purpose
of our study was to explore haematology nurses' perspectives of their patients’ places of care and death.
Method: Qualitative description, based on thematic content analysis. Eight haematology nurses working in
secondary and tertiary hospital settings were purposively selected and interviewed. Transcriptions were coded
and analysed for themes using a mainly inductive, cross-comparative approach.
Results: Five inter-related factors were identiﬁed as contributing to the likelihood of patients’ receiving end of
life care/dying in hospital: the complex nature of haematological diseases and their treatment; close clinician-
patient bonds; delays to end of life discussions; lack of integration between haematology and palliative care
services; and barriers to death at home.
Conclusions: Hospital death is often determined by the characteristics of the cancer and type of treatment.
Prognostication is complex across subtypes and hospital death perceived as unavoidable, and sometimes the
preferred option. Earlier, frank conversations that focus on realistic outcomes, closer integration of palliative
care and haematology services, better communication across the secondary/primary care interface, and an in-
crease in out-of-hours nursing support could improve end of life care and facilitate death at home or in hospice,
when preferred.
1. Introduction
There are over sixty haematological malignancy subtypes (Arber
et al., 2016; Swerdlow et al., 2016), and these ‘blood cancers’ are often
categorised as leukaemias, lymphomas and myeloma. While the dif-
ferent diseases vary in presentation, prognosis and management, they
share a common origin, arising from abnormal blood and bone marrow
cells (Howard and Hamilton, 2013). Collectively, haematological ma-
lignancies account for around 10% of all new cancers diagnosed in
England (Oﬃce for National Statistics, 2016). Although many are in-
dolent (e.g. follicular lymphoma and chronic lymphocytic leukaemia),
and behave like chronic diseases, others (e.g. acute myeloid leukaemia)
are often aggressive (NICE, 2003).
Management varies by subtype: some are curable with intensive,
toxic chemotherapy, associated with long periods of hospitalisation;
others are incurable from diagnosis and managed with intermittent or
continuous oral chemotherapy (NICE, 2003). Clinical pathways and
prognosis depend on the disease, its response to treatment, and the
patient's characteristics (Roman et al., 2016; Smith et al., 2015, 2018a).
Illness trajectories may include lengthy periods of remission and re-
lapse, as well as the potential for sudden deterioration, and the tran-
sition towards the last weeks or days of illness can be unclear (Button
et al., 2017; Smith et al., 2010). Prognostication is notoriously diﬃcult
(Auret et al., 2003; Hui et al., 2016; Odejide et al., 2014), which has
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signiﬁcant implications for the timely organisation and delivery of end
of life care (LeBlanc and El-Jawahri, 2015).
Patients with haematological malignancies are more likely to die in
hospital than people with other cancers, both in the UK and elsewhere
(Dasch et al., 2016; Howell et al., 2010; National Cancer Intelligence
Network, 2011); they are also less likely to be referred to specialist
palliative care and hospice services (Adsersen et al., 2017; Earle et al.,
2008; Howell et al., 2011; Hui et al., 2012), and when they are, it is
often close to the time of death (Hui et al., 2014; LeBlanc et al., 2015).
A key concern is that patients with blood cancers may end life amid
aggressive, intensive treatment, still hoping for cure, and without pal-
liative care input (LeBlanc, 2018; LeBlanc et al., 2017). Specialist pal-
liative care be absent despite a high symptom burden resulting from
bone marrow failure and psychological distress (Hochman et al., 2018;
Manitta et al., 2011; Zimmermann et al., 2013).
Delivery of quality care to patients at the end of life, and under-
standing where best that care should take place, have long been
prioritised on national and international research agendas (Higginson,
2016; Morris et al., 2015; WHO, 2004). Recent studies are beginning to
question the desirability and feasibility of home death (Fjose et al.,
2018; Hoare et al., 2015; Milligan et al., 2016) and challenge as-
sumptions regarding delivery of palliative care in acute hospitals
(Robinson et al., 2014, 2015, 2016). Results from a large-scale Aus-
tralian study (Eagar et al., 2018), for example, show that symptom
outcomes were better for patients receiving palliative care in hospital
than at home, although the reasons for these diﬀerences were unclear.
The views of haemato-oncologists and palliative care specialists
concerning end of life care for blood cancer patients are increasingly
reported (Hui et al., 2015; McCaughan et al., 2018; Odejide et al., 2014;
Wright and Forbes, 2014), yet little is known about the perspectives of
haematology nurses, including their perceptions of reasons for the
predominance of hospital deaths. The dearth of European research in
this area, identiﬁed a decade ago by Grundy and Ghazi (2009), still
prevails. Elsewhere, we identiﬁed only two publications, based on
qualitative interviews with Australian nurses (McGrath and Holewa,
2006, 2007), which revealed concerns about the intensive nature of
hospital-based treatments at the end of life, and lack of integration with
palliative care. However, these ﬁndings were published over a decade
ago, and their applicability to current UK practice is unclear.
The views of specialist nurses are crucial, however, due to their key
role in discussing end of life care with patients and families and facil-
itating preferences (Lobban and Perkins, 2013). Our study therefore
aimed to elicit the views of UK haematology nurses on their patients’
places of care and death. These interviews comprise one strand of a
larger qualitative study, designed to capture the views of doctors and
nurses working in haematology and specialist palliative care settings
(McCaughan et al., 2017, 2018), as well as relatives of deceased pa-
tients (McCaughan et al., 2019). The study ﬁndings are reported in a
series of cross-referenced publications, in order to accommodate the
broad range of perspectives emanating from the diﬀerent groups of
participants.
2. Methods
2.1. Study design
Methods are described below using consolidated criteria for re-
porting qualitative studies (COREQ) (Tong et al., 2007). A qualitative
descriptive approach (Sandelowski, 2000) was adopted to gain new
understanding and insights into a phenomenon about which little is
known (Pope and Mays, 2006). Semi-structured interviews were se-
lected as they facilitate ﬂexibility in data collection (Creswell, 2007),
and generate ‘rich’ narratives (Flick, 2014). Methods were consistent
with the interpretivist paradigm; we sought to understand the sub-
jectivity of nurses' perspectives within the complexity of social pro-
cesses (Broom and Willis, 2007).
2.2. Setting and participant recruitment
The study was conducted within the UK's Haematology Malignancy
Research Network (HMRN: www.hmrn.org) (Smith et al., 2018b). This
is a unique collaboration between university academics, National
Health Service (NHS) clinicians, patients and carers, that facilitates
research using a range of methods, including qualitative studies, with
the purpose of generating evidence to improve clinical practice. As we
sought interviewees who could provide rich data, we purposively se-
lected (Patton, 2015) experienced haematology nurses from within the
HMRN area, based on their role, years of practice and years of hae-
matology nursing. Thirteen nurses were informed about the study by
email, sent an information sheet, and asked to contact the researcher if
they wanted to take part. Eight were interviewed, across four secondary
and tertiary care hospitals; ﬁve agreed but could not take part due to
work commitments. Interviewees were either ward/area managers or
clinical nurse specialists, with between nine and 31 years nursing, and
seven and 18 years haematology experience; some had transplant ex-
perience and others were skilled in working with patients from parti-
cular diagnostic groups. All had provided care for patients dying from
their disease, and their families and friends, and had organised end of
life care in diﬀerent settings.
2.3. Data collection
Interviews were carried out during 2014, by DH, in private, at the
nurses' places of work. A semi-structured topic guide (Table 1) was
developed from existing literature and experiences of the study team; it
was used ﬂexibly to allow for unanticipated responses. Issues explored
evolved as the study proceeded, with early insights informing sub-
sequent interviews (Ritchie and Lewis, 2003). Data collection ceased
after eight interviews that captured a wide range of nurses’ perspectives
relating to the research questions, drawn from their varied experiences
of working in diﬀerent clinical settings (Baker and Edwards, 2012).
Interviews lasted 45–90min and, with participant consent, were audio-
taped and transcribed verbatim.
2.4. Analysis
Analysis involved qualitative description (Sandelowski, 2000),
based on thematic content analysis, an approach considered well-suited
to questions relevant to practitioners and policy makers (Green and
Thorogood, 2018, page 258). Two researchers undertook data analysis
(DM, DH), both qualiﬁed nurses, experienced in qualitative methods in
applied health services research and haematology. Interviews were
summarised through dynamic engagement with the dataset, while
staying close to participants' accounts (Sandelowski, 2000). Analysis
was mainly inductive: we drew on the data to generate meaning, with
the aim of transforming the ‘raw’ data into a new and coherent depic-
tion of the phenomena under scrutiny (Thorne, 2000). Guided by the
research questions, our approach to data analysis balanced both in-
ductive and deductive orientations (Green and Thorogood, 2018, page
252).
Transcripts were read and re-read for familiarisation, and initial
codes (units of meaning) and themes identiﬁed. These were then
Table 1
Interview topic guide.
Haematology nurses were asked about their perspectives on:
• place of care and death in their patients
• reasons why hospital deaths predominate
• factors preventing and promoting care and death at home
• factors associated with the primary/secondary care interface
• factors aﬀecting whether people achieve their preferred place of care and death
• issues speciﬁc to haematology compared to other conditions
• changes that could facilitate death at home or closer to home
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expanded and modiﬁed through a reﬂexive and interactive process of
‘interrogating’ the data, in the search for common patterns and deviant/
negative cases (Pope et al., 2000). Electronic spreadsheets were used to
facilitate data summary and to enable easy comparison within and
between cases. We aimed to move towards a detailed, nuanced inter-
pretive account of the ﬁndings (Sandelowski, 2010), through analytic
processes that facilitated data synthesis and interpretation. Reﬂective
notes and memos formed the basis of regular discussions (DM, DH) to
agree and reﬁne codes and emerging themes. Discussing disagreements
helped to reﬁne data coding and interpretation, thereby enhancing ri-
gour in the analytic process (Barbour, 2001).
3. Ethical approval
NHS ethical approval was obtained (Yorkshire and The Humber
REC: 11/YH/0306). Participants were given verbal and written in-
formation about the study aims and their involvement and were told
they could withdraw at any time. Written consent was sought from
individuals prior to interview and assurances given concerning con-
ﬁdentiality and anonymity.
4. Findings
The haematology nurses perceived hospital death as likely to pre-
dominate amongst their patients due to a complex interplay of inter-
related factors. Five themes were identiﬁed that explicate these factors:
(i) the complex nature of haematological malignancies and their
treatment; (ii) close clinician-patient bonds; (iii) delayed end of life
discussions; (iv) lack of integration of palliative care services; and (v)
barriers to death at home. Inter-related factors perceived as inﬂuencing
likelihood of hospital death are summarised in Fig. 1 and described
below, with verbatim quotes.
4.1. The complex nature of haematological malignancies and their
treatment
Hospital death was often attributed to the complex characteristics
and unpredictable pathways associated with haematological malig-
nancies. Nurses noted that the possibility of cure at a late stage, as well
as the potential for sudden deterioration and death at any point in the
trajectory, made it diﬃcult for haematologists to estimate prognosis
and so identify the ‘right’ time to stop or de-escalate treatment, and
initiate end of life discussion and planning. Patients with aggressive
disease, who often experience prolonged and intensive treatment in
hospital, were considered particularly prone to rapid death. However,
patients with indolent pathways were also considered susceptible to
sudden decline due to the onset of sepsis or bleeding, which can act as a
‘trigger’ for hospital (re-)admission and result in hospital death.
‘I had somebody who was palliative and they collapsed at home, there
was a 999 and they ended up through A&E in ICU – they didn't want to
come into hospital, they didn't want IV antibiotics, they didn't want es-
calated treatment and wanted to die at home’ (Haematology Nurse 4)
Several nurses compared the trajectories of haematological and non-
haematological cancers, commenting that the latter tended to be more
predictable, with linear progression towards terminal disease, and
clearer demarcation between curative and non-curative stages. These
nurses suggested that the characteristics of non-haematological cancers
make it easier for clinicians to determine when to stop treatment and
begin planning end of life care.
‘I think with oncology patients … it's a gradual decline and they can kind
of … decide when enough is enough … but haematology is really fast, in
that they become unwell and … the time that they spend when it would
be like their end of life period, you spend trying to save them, and then all
of a sudden … they do die really quickly.’ (Haematology Nurse 8)
Some haematologists were perceived as generally reluctant to dis-
continue chemotherapy until all options had been explored, so they
Fig. 1. Summary of interrelated factors perceived as inﬂuencing likelihood of hospital death in patients with haematological malignancies.
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could be assured they had ‘tried everything’ to meet (particularly
younger) patients' hopes and expectations for cure. Uncertain out-
comes, and the increasing availability of new treatments, were said to
be associated with prolonged and intensive therapy that could leave
patients too depleted for home transfer after chemotherapy cessation.
‘while there's the newer and novel agents, there is always that possibility,
that you could try this, we could apply that’ (Haematology Nurse 4)
‘for most of them [patients], I think there is unrealistic expectations
about outcome … and they [patients] persevere and persevere’
(Haematology Nurse 3)
‘they would be too unwell to go home, you wouldn't get them home’
(Haematology Nurse 1)
Escalation of treatment (e.g. use of continuous positive airway
pressure – CPAP; admission to high dependency/intensive care units) in
advanced disease, was perceived by nurses as contentious, and linked to
increased risk of hospital death. Despite showing awareness of the
diﬃculties haematologists face making decisions about critical care
interventions, one interviewee commented that ‘just because you can do
something, it is not necessarily the right thing to do’. In the nurses' ex-
perience, patients often died in intensive care, and instances were re-
called when haematology and intensive care doctors seemingly held
diﬀering perspectives regarding the risks and beneﬁts of escalation.
‘the registrar said, “I want to put him on some CPAP”. Now they had got
a DNR [do not resuscitate order] in place with this patient… he was over
80 … and they [intensive care unit consultant] said he wasn't to go to
ICU… the ICU people didn't think it was appropriate, so he didn't end up
getting it’ (Haematology Nurse 2)
4.2. Close clinician-patient bonds
Nurses frequently referred to the strong bonds between patients and
the clinicians looking after them, due to lengthy periods of in-hospital
treatment and outpatient follow-up. Patients and family members were
described as feeling ‘safe and secure’ in the care of staﬀ whom they know
and trust, and ‘at home’ in the hospital environment. The majority of
interviewees regarded hospital as the preferred place of care/death for
patients (and their relatives).
‘the family have got so close to us, the patients have got so close to us, it
feels quite normal [for them] to be in hospital … it just feels the right
place to be’ (Haematology Nurse 7)
‘a lot of people choose to die in hospital … they just feel safe … this is
their second home’ (Haematology Nurse 8)
Nurse participants appeared to derive high levels of satisfaction
from providing holistic care to patients ‘from diagnosis until the end of
their journey’, and described themselves as frequently unwilling to ‘let
go’ of ‘their’ patients after treatment cessation. Reluctance to hand over
to palliative or district nursing care sprang from concerns patients
might feel they were ‘washing [their] hands’ of them after treatment
failure, and that patients would lack time to form relationships with
‘new’ nurses following hospital discharge.
‘we haven't been good at letting go of our patients … we like looking after
them from the cradle to the grave … When it becomes palliative, in terms
of going to a diﬀerent ward, diﬀerent environment … it's diﬃcult … for
the nurses…, relatives…, patient…, doctors…, relationships have been
forged …, the end of life periods might be [too] short … to forge [new]
relationships' (Haematology Nurse 4)
‘somebody new… people coming in at the very end, when they often feel,
oh, why is that, are you done then with me, are you washing your hands
of me?’ (Haematology Nurse 5)
4.3. Delayed end of life discussions
Haematologists' reluctance to ‘give up’ on patients, and patients'
wishes to continue treatments that oﬀer hope for remission or cure,
were identiﬁed as contributing to delayed end of life discussions.
Younger patients were often described as ‘in denial’ that death might be
an outcome, and reluctant to engage in end of life conversations.
‘the patients look to the doctors to kind of save them … When you have
got a patient asking for help, it's diﬃcult to say, I don't think you are
going to survive this, you should go home’ (Haematology Nurse 1)
‘I was trying to ﬁnd out her preferred place [of death] and she was kind
of blocking it all … she was in denial about it’ (Haematology Nurse 6)
Nurses emphasised the need for early, frank discussions between
haematologists and patients/family members about likely treatment
outcomes, to avoid raising unrealistic expectations.
‘I think there is a lack of honesty about what the treatment will do for the
patient … if you're given the option to have chemo you are going to do
that, unless it's presented as “we could do this, but actually it won't be
eﬀective for you”’ (Haematology Nurse 3)
While recognising that identifying the appropriate time to begin
talking to patients about end of life preferences was diﬃcult for hae-
matologists, nurses regarded timely elicitation of this information as
essential to allowing suﬃcient time to organise end of life care at home
or in hospice. Delayed discussions were said to result in hospitalised
patients becoming too ill to consider alternative end of life options, and
therefore remaining in hospital to die.
‘I was thinking we should be having this [end of life] conversation with
him, but he was too unwell’ (Haematology Nurse 6)
‘sometimes patients can deteriorate very quickly … often it's diﬃcult to
get them there [hospice] then, so I think it's about … trying to broach the
subject, a bit sooner’ (Haematology Nurse 7)
Delays initiating ‘diﬃcult’ discussions with patients were partly
attributed to varying levels of conﬁdence amongst haematologists.
‘I've witnessed some excruciating conversations and some fantastic ones,
so it is, it's entirely dependent on who does it.’ (Haematology Nurse 5)
Nurses commented that sustained and close contact with patients
and relatives often alerted them to small changes in a patient's condi-
tion, which doctors might be unaware of, and provided them with in-
sights (e.g. into preferences) they regarded as useful during multi-
disciplinary team meetings. Most attended such meetings regularly, and
felt their participation was welcome and valued, though a minority
reported negative reactions from medical staﬀ to suggestions about
considering switching to a palliative focus to care.
‘we discuss a lot of treatment options and outcomes … and people get
their say … and I think the nurses on the ward are listened to … their
comments are taken into consideration … ’ (Haematology Nurse 5)
‘to be honest, sometimes they [haematologists] are very dismissive of us
… I mean I was made to feel I want to put everyone onto the LCP
[Liverpool Care Pathway] … and I get belittled for that … ’
(Haematology Nurse 2)
4.4. Lack of integration of palliative care services
Nurses reported wide variation in haematologists’ palliative care
referral patterns, and drew comparisons with the management of pa-
tients with other cancers, where referrals usually occur much earlier in
the pathway.
‘one consultant may be very good at putting people on palliative care …
and fast track discharging… and a diﬀerent consultant doesn't agree and
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thinks he's trying to kill them by not giving more treatment’
(Haematology Nurse 3)
‘there's a very deﬁnite split between haematology and oncology … on-
cology moves on … to palliative care services maybe earlier than hae-
matology … With some of the haematology patients, that doesn't happen
until the very last hours or very last days of life … ’ (Haematology
Nurse 4)
With the exception of severe pain in myeloma, patients were said to
rarely experience the complex symptoms speciﬁed in criteria for re-
ferral to hospital specialist palliative care teams.
‘palliative care didn't want to come and see him because they were saying
he didn't have complex needs at that point’ (Haematology Nurse 3)
The nurses regarded themselves as capable of managing most end of
life symptoms, and able to provide emotional support to patients and
family members.
‘we manage their anaemia and thrombocytopenia … most of it we can
manage ourselves … If there's symptoms that we can't manage, cause the
myeloma patients and the lymphoma patients can have a lot of sort of
pain … they need more input really… The leukaemias don't tend to have
too much of a problem with that … ’ (Haematology Nurse 5)
However, caring for dying patients on a busy acute haematology
ward could be diﬃcult due to time constraints. Moreover, nurses were
concerned about losing contact with ‘outliers’, transferred to other
hospital wards to facilitate admission of acutely ill patients.
‘we're just so busy, sometimes only 2 people on at night for 20 patients
and if you've got someone who's dying, it's crap, it's awful’
(Haematology Nurse 1)
‘sometimes we have to move patients oﬀ here [haematology ward] to get
people in that need chemo … The doctors would go round and see them
anyway every day … it's just the nurses they wouldn't have that re-
lationship with … ’ (Haematology Nurse 8)
Some participants had access to beds dedicated to the provision of
palliative care in the hospital where they worked, which were close to
the specialist ward/unit and so allowed haematologists to maintain
contact with patients. This was seen to facilitate good end of life care,
but was not available in all settings.
‘it's a little 18 bedded unit, very specially for haematology and oncology
… following treatment and for giving [supportive] treatment so yeah, it's
deﬁnitely been a great improvement’ (Haematology Nurse 7).
Hospice services were said to be ‘rarely’ accessed. Reasons given for
this were patients' lack of awareness or negative perceptions of hospice,
coupled with disinclination to leave haematology care.
‘making the decision to go somewhere that's quite new, at that time …
that's hard … it's about convincing people that is the best place for them
to go … If they're well enough, we ask them to maybe visit the hospice
with the family … it's the unknown that's frightening’ (Haematology
Nurse 7)
Lack of available hospice beds was also problematic, particularly
when a bed was required at short notice and the patient rapidly dete-
riorating.
‘there's a ﬁnite amount of beds available at the hospice’ (Haematology
Nurse 4)
‘sometimes patients deteriorate very quickly so by the time the bed be-
comes available they are not well enough to travel’ (Haematology Nurse
7)
Inconsistent policies concerning administration of supportive
therapies (e.g. blood product transfusions), was said to further com-
pounded diﬃculties in accessing hospice care.
‘they [hospice] won't take them [patients with haematological condi-
tions] if they need blood and platelets' (Haematology Nurse 3)
4.5. Barriers to death at home
Perceived barriers to home death included delays in hospital dis-
charge; variable availability of community nursing services; role of
family members; loss of GP contact; and poor communication across
care settings.
4.5.1. Delays in hospital discharge
The need for early elicitation of preferences to facilitate organisa-
tion of community support for patients wishing to die at home was
repeatedly emphasised. Short notice discharge could pose almost in-
surmountable problems for nurses, due to limited time for completion
of paperwork and liaison with community services. Shared responsi-
bility for discharge across the nursing team, and use of fast track pro-
cesses were said to help; but even securing an ambulance to transport
patients home, and being able to ‘spare’ an accompanying nurse, could
be diﬃcult.
‘my heart almost sinks when the patient says ‘I'd like to go home … it
takes up an incredible amount of time … phone the hospice, phone the
district nurses, get stuﬀ in place, like a bed, sometimes you don't have
time to do it … and the patient is deteriorating in front of your eyes …
Sometimes, a lot of the time, you have to stop and say, you are too unwell
to go home now. I think that's one of the reasons people don't die at home
… if you get someone home, you see it as a major achievement’
(Haematology Nurse 1)
‘I couldn't get an … ambulance … I thought he was going to die on the
way … I couldn't go in the ambulance with him … ’ (Haematology
Nurse 3)
Nurses commented that patients whose discharge occurs at a very
late stage often become too ill to leave hospital before arrangements are
complete, or die soon after arriving home.
‘most people, if they say, I want to die at home, they don't literally mean,
I want to be whisked home hours before I die … I imagine people want to
spend a bit of time at home and then die … not just literally get shoved
through the door’ (Haematology Nurse 2)
4.5.2. Variable availability of community nursing services
District and palliative care nursing was perceived as ‘patchy’, with
gaps in out-of-hours care being cited as a major reason for patients
being unable to leave hospital, or readmitted. The Marie Curie night
sitting service (a registered UK charity providing nursing care for
people with life-limiting diseases) was viewed as an extremely valuable
source of support, but was often said to be limited.
‘community is very diﬃcult in terms of them being staﬀed in a way that
patients can go home and be fully supported … The diﬃculty obviously
would be evenings and weekends … We have delayed discharges of
people wanting to go home because we have not been able to get as many
carers in as we would need’ (Haematology Nurse 4)
Relatives, often anxious due to lack of overnight support, were de-
scribed as likely to contact out-of-hours’ services, or the haematology
ward if the patient's condition deteriorated, resulting in patients dis-
charged home for end of life care ‘bouncing’ back into hospital.
‘People are in pain during the night, people are afraid during the night,
people are awake during the night and a lot more of it is magniﬁed so
much more during the night than it usually is during the day, when
they've got lots and lots of people around.’ (Haematology Nurse 4)
‘when the patient has diﬃculty at home … people bounce back in and
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end up dying where they didn't particularly want to be’ (Haematology
Nurse 4)
4.5.3. Role of family members
Haematology nurses commented that patients were often more, and
relatives less, likely to express a preference for home death, making
planning end of life care diﬃcult.
‘it [dying at home] might be the patient's choice … the family might be
dead against it’ (Haematology Nurse 9)
‘I think they [family members] feel scared at the thought of having them
[patients] at home … they often say, we'd rather be in hospital’
(Haematology Nurse 7)
Having family able and willing to provide care was regarded as
essential for home care/death, but was not always available (e.g. pa-
tients with frail/working relatives, living alone or not having relatives
nearby).
‘it's often people that don't have family support that can't be managed at
home for end of life care … because they just need somebody. The ser-
vices that we get, the maximum is four calls a day, so in between those
calls, they're on their own … So unless they've got a family member who
can… sort of, be around and in and out, then it's impossible for people to
really safely be at home’ (Haematology Nurse 5)
‘people are working … years ago they would rally round to take care of
their loved one’ (Haematology Nurse 1)
Nurses shared a perception that many people have unrealistic ex-
pectations of death at home, based largely on media reports. They
commented that onset of symptoms (e.g. dyspnoea and bleeding), could
provoke signiﬁcant distress in patients and relatives, and shift pre-
ferences from home to hospital-based care.
‘in the media … the reality of dying at home is not portrayed … it's very
diﬀerent from the “home sweet home” image’ (Haematology Nurse 4)
‘a lot of haematology patients are quite worried about bleeding … and
how that would be managed at home … I think that kind of frightens
them … ’ (Haematology Nurse 7)
Parents of young children in particular were thought to often prefer
patient death to occur outside the home, in an attempt to mitigate
distress.
‘you've got the dying person in the living room … the patient and wife or
husband are thinking, we can't do that, it's too scary for the children …
Practically, it's a lot easier for them to be … in hospital … or go to the
hospice’ (Haematology Nurse 1)
4.5.4. Loss of contact with GP
Loss of contact between patients and GPs was attributed to the
predominant role of haematologists in providing care. GPs were per-
ceived as often ‘out of the loop’ and lacking current information about
treatment and progress.
‘they might not see the GP for two years … they would rather we deal
with it all’ (Haematology Nurse 1)
‘we don't discharge palliative patients [to GP]’ … in terms of going home,
they still remain in our system’ (Haematology Nurse 4)
Several nurses noted that it is ‘drilled into’ patients to contact hae-
matology specialists, rather than their GP, for any problems relating to
their cancer.
‘when they're ﬁrst diagnosed … we kind of instil it into them that they
must ring if they've got any problems and not to ring the GP… we are the
ones doing the chemo and know about the side eﬀects … it's drilled into
them to ring us about everything … I can see how the GP does lose
contact’ (Haematology Nurse 7)
‘they [patients/relatives] have had a lot of contact with hospital and then
if they [patients] become unwell … they'll often contact us ﬁrst, ﬁrst line
of support, and end up getting admitted’ (Haematology Nurse 6)
4.5.5. Poor channels of communication across care settings
Poor channels of communication across the primary/secondary care
interface, including incompatible electronic record systems that, one
participant said, ‘don't speak to each other’ were considered to impede
achievement of home death. ‘Flagging’ patients in secondary care, via a
system similar to that within the Gold Standards Framework (‘Gold
Standard Framework Proactive Identiﬁcation Guidance (PIG)
Registration Form’) (www.goldstandardsframework.org.uk), was sug-
gested as a potential means of alerting primary care staﬀ to people
possibly in the last year of life, who are likely to require GP, community
nurse and out-of-hours support, if they want to die at home.
‘primary and secondary care historically have never spoken to each other
very well. Communication has been very poor … we need to tighten that
up. We can't see what's gone on at home, the same way the GP can't see
what we've discussed here [hospital] … Some sort of system where you
could [access] community [and] hospital [records] … would be perfect’
(Haematology Nurse 4)
An absence of systematic and routine recording of end of life dis-
cussions, resulting in the need to re-initiate sensitive conversations that
had already taken place, was also noted.
‘I think documentation could be better… so that everybody knows what's
been said and when, and clearly documented … what the preferred place
of death was, or why a discussion hadn't taken place … then you could
go straight to the notes … and everyone would be aware of this decision’
(Haematology Nurse 5)
5. Discussion
A series of complex, interrelated factors were identiﬁed by haema-
tology nurses as contributing to hospital death among patients. The
most signiﬁcant relate to the disease characteristics (unpredictable
trajectories, indistinct transitions, diﬃculties with prognostication),
their often intensive treatments and uncertain outcomes. Other factors
were also described, some of which were considered more amenable to
modiﬁcation (e.g. availability of community nursing services, night
sitters and hospice beds). Earlier discussions, focussing on realistic
outcomes, better integration between specialities and improved com-
munication channels across settings were factors perceived as having
the potential to improve end of life care and facilitate achievement of
preferences.
A further reason for hospital death identiﬁed by nurses, was that
patients may prefer to die in this setting, due to the close bonds between
haematology staﬀ, patients and family members. Relatives' preference
for patient death in hospital was also linked by nurses to anxieties
concerning the adequacy of home care and their own ability to provide
care. This reﬂects ﬁndings from an interview study with family mem-
bers providing home care (Totman et al., 2015), that revealed intense
feelings of responsibility, isolation and anxiety. Furthermore, a narra-
tive literature review (Morris et al., 2015) highlights caregivers’ own
needs for emotional support, information and practical assistance with
hands-on care.
Continuation of treatment until close to death was considered a
major contributor to hospital death in our study, though often per-
ceived as unavoidable, particularly in younger patients receiving in-
tensive chemotherapy for aggressive disease. Administration of treat-
ment close to death is considered overly aggressive by some (Beaussant
et al., 2018; Hui et al., 2014), but may be due to haematologists’ con-
cerns that the potential for cure still exists (even in advanced disease),
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the availability of multiple and/or new lines of treatment and diﬃculty
identifying refractory disease and the end of life phase (Hui et al., 2015;
McCaughan et al., 2017; Odejide et al., 2014); it may also be based on
often unrealistic hope for response or cure, driven by patients and
clinicians, as described in our own study and elsewhere (Laryionava
et al., 2018; Odejide et al., 2016).
Nurse participants regarded decisions to escalate treatment as
contentious and linked to increased likelihood of hospital death, par-
ticularly in elderly patients with advanced disease. Escalation has been
described by others as complex and emotive (Hill, 2010), with tensions
potentially arising between clinicians due to diﬀering perceptions of
risk and beneﬁt, as noted by our interviewees. Diﬃculties arise because
patients are generally severely ill on referral to critical care, and sur-
vival often poor (Azoulay et al., 2015; Cheng et al., 2016; Hill, 2010).
Although these issues have resulted in calls for timely communication
and close collaboration between teams (Cheng et al., 2016), a recent UK
study suggests that the appropriateness of escalating care is often not
considered until patients are acutely unwell and outreach teams inter-
vene (Pattison et al., 2015). Current UK guidance recommends, how-
ever, that certain haematology patients (i.e. with good performance
status) are considered for intensiﬁcation (Wise et al., 2015).
Participants said their sustained contact with patients and relatives
gives them unique insights into the values and preferences of in-
dividuals, as well as changes in a patient's condition that should be
considered during decision making. However, two said their perspec-
tives were neither routinely sought nor appeared valued by colleagues,
causing them to feel angry and upset. Canadian haematology nurses
have described how their in-depth patient knowledge facilitates early
recognition of dying, but how negotiating the contradictory tasks of
ﬁghting disease while preparing patients for end of life can cause both
personal and professional conﬂict, distress and burn-out (Leung et al.,
2012). Similar existential, moral and ethical diﬃculties have been re-
ported in studies investigating the role of critical care nurses in Canada
and the USA (Bach et al., 2009; Robichaux and Clark, 2006), and fur-
ther UK research into these issues is warranted.
The notion of dying at home as a quality indicator of a ‘good death’
is increasingly coming under scrutiny, and indeed may not be feasible,
or the main priority in all circumstances, for all people (Gomes et al.,
2015; Holdsworth, 2015; Pollock, 2015). Hospitalisation is regarded by
some as potentially unavoidable late in the cancer trajectory, however,
with optimisation of inpatient care a key priority at this time, more so
than place of death (Numico et al., 2015). Little is known about pre-
ferences of patients with palliative care needs for place of care during
periods of acute illness, or of any beneﬁts they (and their family
members) may experience from hospitalisation at end of life (Robinson
et al., 2015). In our study, nurses commented that end of life experi-
ences may diﬀer for patients in hospitals lacking a dedicated haema-
tology ward, or who are outliers in other areas. They commented that
caring for dying patients alongside those who are acutely ill and re-
ceiving treatment can be challenging and alluded to time pressures in
acute environments as constraining their capacity to meet the needs of
dying patients and their relatives, particularly for psychological and
emotional support in relation to existential distress. Currently, it is not
known whether haematology nurses feel adequately prepared to pro-
vide end of life care, either educationally or emotionally (Bloomer
et al., 2013) as research exploring such issues is lacking in the UK.
Frank, early and realistic discussions regarding treatment outcomes
and possible cessation, were perceived as vital for successful advance
planning, particularly where home death is preferred. Delayed discus-
sions were primarily attributed by nurses to prognostic uncertainty and
lack of clear indicators of disease progression, with resultant challenges
for haematologists in identifying the best time to initiate such con-
versations. Our study interviewees also reported variation in haema-
tologists' conﬁdence in commencing ‘diﬃcult’ discussions. A recent UK
review reports varying levels of satisfaction among haemato-oncolo-
gists with their communication skills training and little evidence of
consistency in teaching beyond medical school and specialist training
(Christie and Glew, 2017). Such interventions are recommended,
however, if the communication challenges faced by haematologists are
to be met (Dharmarajan et al., 2016; Odejide et al., 2016; Christie and
Glew, 2017).
A further diﬃculty is deciding if/when to refer patients to palliative
care services (Auret et al., 2003; Manitta et al., 2010). Nurses in our
study reported varying levels of collaboration between haematology
and palliative specialists and inconsistent referral practices, although
recent studies indicate increasing interdisciplinary working and co-lo-
cation (McCaughan et al., 2018; Wright and Forbes, 2014). The nature
and extent of the haematology nurses’ involvement in referral decisions
was unclear, as was their role in providing palliative care, underscoring
how little is known about the role of nurses in these activities (Kirby
et al., 2014), despite the importance placed on team-based approaches
to managing timely and eﬀective transitions.
The beneﬁts of early palliative care for patients with blood cancers
(mitigating symptoms, providing psychosocial support and guiding
patients’ expectations) are increasingly acknowledged (Boucher et al.,
2018; Hochman et al., 2018). Some authors, however, report that
under-utilisation of this service is likely to persist until palliative care is
conceptualized as an “extra layer of support”, additional to standard
care, and alongside active treatment (LeBlanc et al., 2017). The ap-
propriateness and provision of palliative care should not be dependent
upon a particular prognosis, which leads to late or absent referrals of
patients to palliative care (Beaussant et al., 2018).
Our ﬁndings concur with other UK studies indicating that haema-
tology patients did not always have complex symptoms requiring spe-
cialist management (with the exception of myeloma), that access to
specialist palliative care services may be curtailed by strict referral
criteria and that inpatient palliative care beds were lacking
(McCaughan et al., 2018; Wright and Forbes, 2014). Such limited access
(compared to other cancers) may unintentionally reinforce patient
preferences to remain with the haematology team for end of life care.
Moreover, early palliative care is reportedly feasible and eﬀective for
haematology patients (El-Jawahri et al., 2016; Porta-Sales et al., 2017)
and could familiarise them with this facility, thus dispelling some of the
negative perceptions said to contribute to under-use of services (Wright
and Forbes, 2014; Zimmermann et al., 2016). Interviewee suggestions
for increased access to hospital palliative care beds echo those of hae-
matologists (Wright and Forbes, 2014).
Barriers to patients with haematological cancers accessing hospice
care (inconsistent transfusion policies, lack of rapid-access beds), are
widely reported in the UK (Brown and Bennett, 2007; Wright and
Forbes, 2014), the US (Odejide et al., 2017), and elsewhere (Cheng
et al., 2015), and were also identiﬁed in our study. Treatment viewed as
‘symptom control’ by haematologists is often considered ‘active’ by
palliative care physicians, and not provided in hospices (Auret et al.,
2003). Although evidence is lacking (e.g. regarding palliative transfu-
sions), the need to develop guidelines to simultaneously meet curative/
life-prolonging and palliative care needs has been emphasised (Chin-
Yee et al., 2018; Epstein et al., 2012).
Many barriers to home care identiﬁed in our study (e.g. unavail-
ability of carers, gaps in community nursing services) are applicable to
other cancers (National End of Life Care Intelligence Network, 2015;
Sarmento et al., 2017). Limited evidence exists about informal carer
perceptions of their links with healthcare professionals providing end of
life care in the home setting (Holdsworth, 2015; Seamark et al., 2014;
Shepperd et al., 2016). A recent Australian study, however, illuminates
the vital role family, friends and neighbours play in supporting home
death and raises questions about optimal integration of informal and
professional systems (Leonard et al., 2018). A UK study reports the
important role of community nursing in the last three months of life in
promoting achievement of home death (Gomes et al., 2015). However,
while improved home palliative care may enhance patient and carer
experiences (Sarmento et al., 2017), it is unlikely to prevent hospital
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admission of patients whose condition deteriorates suddenly and
acutely (Numico et al., 2015). Delivery of optimal end of life care to
patients with haematological malignancy, in line with their stated
preferences for place of care and death, demands highly responsive,
multidisciplinary teams to collaborate closely, across community, hos-
pital and hospice settings (Pasquale et al., 2006, 2014; 2015).
Unrealistic expectations concerning dying were considered a barrier
to home death by our study nurses. Patients and relatives were de-
scribed as unprepared for the patient's deterioration, and fearful about
how and when death might occur, undermining relatives' conﬁdence to
provide care. Numerous studies have similarly reported high levels of
anxiety among home-carers regarding uncertainty about death
(Harding et al., 2012; Martín et al., 2016; McIlfatrick et al., 2018). A
systematic review highlights carers' desires for written information
about disease progression, and training to enable them to feel more
competent in their role (Ventura et al., 2014). These ﬁndings are sup-
ported in a large Canadian study with bereaved caregivers, who said
they valued being taught what to expect as the patient's condition de-
clined and how best to manage symptoms (Bainbridge et al., 2017).
Poor communication channels between haematology and primary
care were linked by nurses to hospital readmission after patient home-
discharge for end of life care. Use of shared platforms across settings
could promote timely access to information, facilitate faster community
palliative care services set up, and increase the likelihood of home
death. Electronic Palliative Care Coordination Systems (EPaCCs) are
currently in use in the UK to support recording up-to-date preferences
of patients thought to be in the last year of life. This system is aimed at
GPs, out-of-hours/emergency services, nursing/palliative care teams,
hospitals, hospices and care homes; views about utility are mixed
however (Petrova et al., 2018; Wye et al., 2016).
It is important to clarify prognostic expectations and patient pre-
ferences despite the diﬃculties we describe. Routine use of the Gold
Standards Framework Proactive Identiﬁcation Guidance (GSF PIG)
(www.goldstandardsframework.org.uk) and Supportive Palliative Care
Indicators Tool (SPICT) (www.spict.org.uk) could help identify patients
in their last 12 months of life, and facilitate achievement of preferences.
O'Callaghan et al. (2014) found high sensitivity, speciﬁcity and pre-
dictive value of the GSF PIG in screening for end of life in their cross
sectional study of 501 hospitalised patients with heart and renal failure,
and a study designed to evaluate SPICT has similarly shown promising
results, though further research is needed (Highet et al., 2014). Hae-
matology speciﬁc tools are currently lacking (Moreno-Alonso et al.,
2018), but would undoubtedly be useful, particularly as so many pa-
tients with these diseases die well within a year of diagnosis. Another
initiative being rolled out in the UK is the Recommended Summary Plan
for Emergency Care and Treatment (ReSPECT) (www.respectprocess.
org.uk) which aims to improve information sharing across settings and
enable patient preferences to be met in emergency situations, when
rapid decision-making is required; the impact of this remains to be seen.
5.1. Strengths and limitations
To our knowledge, this is the ﬁrst UK study to investigate haema-
tology nurses' views of their patients' places of care and death. In-depth
interviews yielded ‘rich’ data, and inclusion of nurses from diﬀerent
settings facilitated capture of a range of perspectives. The number of
nurses included was small, but not atypical of qualitative descriptive
studies, which rely on the quality of data collected for validity, rather
than the number of included participants (Kim et al., 2017). The aim of
our study was relatively narrow; we recruited a speciﬁc sample of
nurses with the expertise to inform the research question; the interview
dialogue was of high quality; and the analytical strategy incorporated
in-depth exploration and interpretation of data to generate new insights
and understanding. Whilst we recognise that the small sample size re-
quires caution in extrapolating ﬁndings, the relatively under-researched
nature of the topic means this is less important than ‘sensitizing’ readers
to new information (Green and Thorogood, 2018). Further studies are
required with larger samples of nurses working in diverse service
conﬁgurations, and in diﬀerent localities.
6. Conclusions and implications
Haematology nurses attributed hospital deaths to several inter-re-
lated factors; the most signiﬁcant being the intensive nature of treat-
ments, and the propensity for sudden deterioration and death.
Prognostication was acknowledged as challenging, and hospital death
was often perceived as unavoidable, and the preferred option for some.
Earlier, frank conversations about end of life care, focussing on realistic
outcomes; closer integration of palliative care and haematology ser-
vices; better channels of communication across settings, adequate
community nursing services and hospice beds, and hospice policies
aligning life-prolonging and palliative care, were perceived as having
the potential to improve end of life care and the likelihood of home or
hospice death, where preferred.
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